CMA Veterinary Pricing Transparency: A Step-by-Step Compliance Checklist

Why this checklist exists

The Competition and Markets Authority's Final Report on the veterinary sector, published in March 2026, set out a package of mandatory remedies covering pricing transparency, treatment cost estimates, ownership disclosure, and consumer protection. CMA Orders implementing these remedies are expected to take effect in September 2026.

For practice managers, this is enforceable compliance with a deadline. The earlier post What the CMA Veterinary Reforms Mean for Independent Practices explained the headline requirements. This guide is the practical checklist — what you need in place, in what order, before the deadline.

If you'd rather work through the compliance status interactively, the CMA Compliance Self-Assessment tool walks through each requirement and flags gaps. This page is the framework the tool is built on.

How the remedies group practically

The remedies fall into five practical workstreams, each requiring different operational changes:

1. Pricing transparency on the website and in-practice
2. Itemised billing and estimates
3. Ownership and corporate disclosure
4. Prescription, dispensing, and treatment information
5. Complaints and dispute resolution

The checklist below is grouped by workstream. Each item is what an enforcing authority will expect to see evidence of.

Workstream 1: pricing transparency

Website price list

• Standardised price list published on practice website
• Covers the services the CMA specifies (registration, consultation, vaccinations, neutering, dental procedures, parasite treatment, end-of-life services as a minimum — confirm against final CMA Order when published)
• Prices presented in a format enabling consumer comparison (clear, not buried in footnotes, no "price on consultation" for listed services)
• Price list dated, with a "last updated" timestamp visible
• Update process documented — when prices change, the website is updated within a defined timeframe (CMA expectation likely to be days, not weeks)
• Archived versions retained — for transparency and dispute resolution

In-practice display

• Equivalent price list visible in reception or waiting area
• Same content as website, same update cycle
• Accessible format (large print available on request, where reasonable)

Process control

• Named person responsible for price list maintenance
• SOP for price list updates — when, by whom, how change is communicated
• Audit log of changes (date, what changed, who authorised)

Workstream 2: itemised billing and estimates

Estimates

• Written estimate provided for any non-emergency treatment over a defined value (CMA Order will specify — likely tied to a percentage or absolute amount)
• Estimate includes line items — consultation, diagnostics, medications, procedures separately
• Estimate dated and signed (or digitally acknowledged) by client before treatment commences (where practicable)
• Estimate retained on the clinical record
• Process for re-estimation if treatment scope changes mid-procedure
• Communication protocol for unexpected costs (consent for additional treatment, costs disclosed in advance)

Itemised invoices

• All invoices itemise consultation, diagnostics, medication, procedures separately
• Medications priced with quantity and unit price (not bundled into a generic "medication" line)
• Diagnostic procedures itemised (each test priced)
• Surgical procedures itemised (procedure, anaesthesia, post-op medication)
• No bundled "treatment package" lines without itemised breakdown available on request

Process control

• PMS/billing system configured to support itemised output (some legacy systems require update)
• Front-of-house staff trained on estimate process
• SOP for estimate creation, client communication, and post-treatment reconciliation

Workstream 3: ownership and corporate disclosure

Ownership disclosure

• Practice ownership clearly disclosed on website (independent, named corporate group, or specific parent entity)
• In-practice signage if required by Order
• If part of a corporate group: which group, with appropriate visual or verbal disclosure
• Updates required on ownership change (mergers, acquisitions, share transfers)

Process control

• Named person responsible for ownership disclosure accuracy
• Process for updating disclosure on corporate change

Workstream 4: prescription, dispensing, and treatment information

Prescription transparency

• Clients informed of right to written prescription for medications (rather than purchase from the practice)
• Prescription fee (where charged) disclosed in advance and on the price list
• No undue restriction on prescriptions — practices cannot inflate prescription fees to discourage external dispensing

Generic vs proprietary

• Where generic alternatives exist for prescribed medications, this is disclosed to the client (so client can make informed choice)
• Practice's dispensing markup transparent if requested
• Cascade prescribing decisions documented and discussed with the client

Treatment information

• Treatment options presented with associated cost ranges (not just one option)
• Risks, benefits, and alternatives discussed and documented (already an RCVS Code of Professional Conduct requirement; CMA reinforces it)
• Out-of-hours arrangements clearly disclosed including any additional cost

Workstream 5: complaints and dispute resolution

Complaints process

• Documented complaints procedure publicly available (website + in-practice)
• Time-bound response commitments (acknowledge within X days, substantive response within Y days)
• Internal complaints log — every complaint, the response, the resolution
• Trend analysis — recurring complaint themes captured and addressed

External redress

• Clients informed of right to escalate to the RCVS for professional conduct issues
• Clients informed of right to raise consumer complaints with appropriate authorities (Trading Standards, alternative dispute resolution body where applicable)
• Disclosure of any approved ADR scheme the practice is a member of

Cross-cutting requirements

Beyond the workstream-specific items, the CMA framework will likely include several cross-cutting compliance requirements:

• Staff training — every member of front-of-house staff trained on the new requirements, with training records (linked to your SOP and training framework)
• Audit cycle — quarterly self-audit against the checklist, findings documented, actions tracked (links to your clinical governance framework)
• Documentation retention — estimates, itemised invoices, complaint logs retained for a period to be specified by the CMA Order (likely several years)
• Evidence pack — practice able to produce evidence of compliance on demand for CMA enquiries (analogous to VMD inspection readiness)

Pre-deadline timeline

If you're starting from scratch, work back from September 2026:

Now (April-May 2026)

• Audit current state against the checklist above
• Identify the largest gaps
• Establish ownership for each workstream
• Brief the team on what's coming

Q2 2026 (May-June)

• Update website with initial price list (even if not perfect — get a public version up)
• Configure PMS for itemised billing if not already
• Draft updated SOPs for estimates, complaints, prescription transparency
• Update risk assessments — pricing-related compliance is a new operational risk

Q3 2026 (July-August)

• Train all staff on new processes
• Run first internal audit against the checklist
• Resolve identified gaps
• Update website and in-practice signage to final state
• Verify ownership disclosure compliance

September 2026

• CMA Orders take effect
• Compliance is now enforceable
• Continue quarterly audit cycle

Q4 2026 onwards

• Embed checklist into ongoing clinical governance audit cycle
• Annual review of pricing transparency framework
• Update on CMA enforcement signals (early enforcement actions will clarify what "compliant" means in practice)

How CMA compliance integrates with wider compliance

CMA pricing transparency is a new compliance stream layered on top of the existing veterinary regulatory environment:

• SOP management — new SOPs for estimates, billing, complaints
• Risk assessments — pricing-related operational risks
• RCVS PSS — overlaps on client communication standards
• Clinical governance — CMA compliance is one stream within the framework
• Staff training and competency — front-of-house staff need new competencies

Practices that already have strong non-clinical compliance systems will find CMA compliance easier to integrate. Practices without an existing framework will find CMA the catalyst for building one.

Getting started

The fastest start:

1. Run the CMA Compliance Self-Assessment tool to baseline current state across the CMA remedy areas
2. Identify the largest gaps — typically itemised billing and ownership disclosure are the easiest wins
3. Assign ownership for each workstream
4. Set the timeline — September 2026 is the deadline, but realistic preparation needs to start now
5. Connect to your wider compliance framework — CMA isn't standalone; it sits within your governance structure

The CMA enforcement environment will clarify over the second half of 2026. Practices that arrive at September with a defensible system and documented evidence will be in a much better position than those waiting for clarity before acting.

---

This guide reflects publicly-available information about the CMA's March 2026 Final Report. It is not legal advice. Final compliance requirements will be set by the CMA Orders, expected in September 2026. For specific compliance queries, consult the CMA's veterinary services case page, the British Veterinary Association's CMA guidance, and your defence body.